Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Rajko Medenica"'
Publikováno v:
Journal of Clinical Apheresis
The rationale for the use of interferon (IFN) in the treatment of multiple sclerosis (MS) is based on its recognized antiviral and immunomodulating actions. The pathogenesis of MS is believed to be due to an immunologic response in a genetically pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4758aad35e7b2ee7c4a9924fe30e2c16
https://doi.org/10.1002/jca.2920090405
https://doi.org/10.1002/jca.2920090405
Publikováno v:
Southern Medical Journal. 85:3S-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::904ce1f86f9eacb23483a421496704d8
https://doi.org/10.1097/00007611-199209001-00004
https://doi.org/10.1097/00007611-199209001-00004
Publikováno v:
Immunological investigations. 26(3)
It has been reported that in HIV infected patients enhanced production of IL-4 and IL-10 in response to stimulation of peripheral blood lymphocytes with phytohemagglutinin is associated with disease progression. Some have proposed that a switch from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf2b9887fb380c2c7ea7775538ba5ce
https://pubmed.ncbi.nlm.nih.gov/9129987
https://pubmed.ncbi.nlm.nih.gov/9129987
Autor:
Rajko Medenica, Sonjoy Mukerjee, Wesley Holland, Thomas Berrigan, Teresa Huschart, Wendy Corbitt, Robert Mencini
Publikováno v:
Southern Medical Journal. 88:S69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59033c7f180dcde2fbf6c00611f81b72
https://doi.org/10.1097/00007611-199510001-00142
https://doi.org/10.1097/00007611-199510001-00142
Publikováno v:
Southern Medical Journal. 88:S45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fb689e2553b36251b150caef47cfbee
https://doi.org/10.1097/00007611-199510001-00084
https://doi.org/10.1097/00007611-199510001-00084
Autor:
Nelson Slack, Rajko Medenica
Publikováno v:
Cancer drug delivery. 2(1)
The efficacy of Human 6 IFN (HLIFN) given in a pulse fashion was determined in a phase II study. Ninety-one cancer patients were evaluated (9 myeloma, 12 breast, 14 prostate, 9 melanoma, 4 renal, 6 astrocytoma, 7 ovarian, 9 large bowel, 7 gastric, 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859fbe190e588bef5d1064f887777f51
https://pubmed.ncbi.nlm.nih.gov/4052926
https://pubmed.ncbi.nlm.nih.gov/4052926
Publikováno v:
Cancer chemotherapy and pharmacology. 1(2)
DDMP, a diaminopyrimidine folate antagonist, was given to 26 tumor patients in a dosage of 50 mg/m2 per week orally, simultaneously with 3 mg CF i.m. or i.v. The CF dose was increased to 30 mg in patients showing evidence of toxicity, and withdrawn i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9b3d680b4c22cd909975fed9e8371e
https://pubmed.ncbi.nlm.nih.gov/373910
https://pubmed.ncbi.nlm.nih.gov/373910
Autor:
Glassy MC; Rajko Medenica Research Foundation, San Diego, CA 92126, USA. markglassy@aol.com, McKnight ME, Kotlan B, Glassy EF, Koda K
Publikováno v:
Human antibodies [Hum Antibodies] 2007; Vol. 16 (3-4), pp. 87-98.
Autor:
Glassy MC; The Rajko Medenica Research Foundation, San Diego, CA 92121, USA. markglassy@aol.com, McKnight ME
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2005 Oct; Vol. 5 (10), pp. 1333-8.
Lessons learned about the therapeutic potential of the natural human immune response to lung cancer.
Autor:
Glassy MC; The Rajko Medenica Research Foundation, 10246 Parkdale Avenue, San Diego, CA 92126, USA. Markglassy@aol.com, Yasutomi J, Koda K
Publikováno v:
Expert opinion on investigational drugs [Expert Opin Investig Drugs] 1999 Jul; Vol. 8 (7), pp. 995-1006.